IRCT20221016056188N1招募中2 期
Comparision of efficacy of 4% hydroquinone alone and combined with Plasma rich in growth factor (PRGF) in the treatment of melasma
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- Female
入选标准
- •female patients with minimum age 18 years old and maximum age 50 years old
- •patients with diagnosed melasma
排除标准
- •history of allergy to the components of formulation
研究者
相似试验
已完成
3 期
Combination of Hydroquinone and Fractional CO2 Laser vs. Hydroquinone Monotherapy in Melasma Treatment: A Randomized Split-face Clinical TrialChloasmaIRCT20171222037987N1Esfahan University of Medical Sciences40
招募中
1 期
The effectiveness of hydroquinone 4% versus hydroquinone 4% with intradermal injection of autologous platelet-rich plasma in the treatment of lichen planus pigmentosus: A comparative split-face clinical trialichen planus pigmentosus of the face or neck for 6 months or longer that has been confirmed by histopathology.lichen planus pigmentosus, hydroquinone, autologous platelet-rich plasmaTCTR20240430003Institute of Dermatology, Bangkok, Thailand15
已完成
不适用
Efficacy of Hydroquinone 2% cream versus Tranexamic Acid InjectioIRCT2017040533244N1Deputy of Research and Technology of Shiraz University of Medical Sciences37
招募中
4 期
Comparative study between topical hydroquinone 4% alone versus its combination with intradermal autologous platelet-rich plasma in the treatment of melasma: a split-face controlled trialMelasmamelasma, autologous platelet-rich plasma, hydroquinoneTCTR20210925002Institute of Dermatology20
已完成
2 期
treatment of melasmamelasma.ChloasmaIRCT2014110919885N1Vice Chancellor for Researc?h, Hamadan university of medical science44